Today, more than 20 million people live with peripheral neuropathy, but many aren’t aware of it. These individuals live with the chronic pain that characterizes this disease, not knowing there is ...
The funding will help Reunion pay for a mid-stage study testing its most advanced medicine — essentially a synthetic version of the hallucinogenic psilocin — in women with postpartum depression.